Skip to main content
. Author manuscript; available in PMC: 2017 Jul 13.
Published in final edited form as: Clin Res Infect Dis. 2015 Aug 3;2(2):1017.

Table 1.

Baseline Patient Characteristics.

Characteristics No C. difficile (n=672) NonToxigenic C. difficile (n=97) Toxigenic C. difficile (n=651) P-value
Age, years (mean, SD) 54.7 (18.6) 55.7 (22.3) 54.9 (23.2) 0.903
Female (n, %) 364 (54.2%) 51 (52.6%) 357 (54.8%) 0.907
Non-White (n, %) 115 (17.1%) 16 (16.5%) 130 (20.0%) 0.360
Inpatient at baseline (n, %) 555 (82.6%) 72 (74.2%) 400 (61.4%) <0.001
Nursing home (n, %) 7 (1.0%) 7 (7.2%) 78 (12.0%) <0.001
Charlson Deyo Score (mean, SD) 1.37 (1.60) 1.32 (1.49) 1.28 (1.53) 0.581
Antibiotics during past 2 weeks (n, %) 425 (62.2%) 54 (54.5%) 359 (50.6%) <0.001
Proton pump inhibitors during past 2 weeks (n, %) 323 (47.3%) 47 (47.5%) 228 (32.1%) <0.001
H2 receptor antagonists during past 2 weeks (n, %) 132 (19.3%) 19 (19.2%) 115 (16.2%) 0.292
Number admissions during previous 28 days:
0 577 (85.9%) 80 (82.5%) 552 (84.8%)
1 86 (12.8%) 14 (14.4%) 91 (14.0%)
2+ 9 (1.3%) 3 (3.1%) 8 (1.2%) 0.614
Number nights in hospital during previous 180 days (mean, SD) 12.6 (16.2) 13.6 (17.9) 10.6 (16.7) 0.042
Number prior positive C. difficile tests:
0 636 (94.6%) 80 (82.5%) 531 (81.6%)
1 29 (4.3%) 13 (13.4%) 97 (14.9%)
2+ 7 (1.0%) 4 (4.1%) 23 (3.5%) <0.001